Skip to main content
. 2016 Jun 8;12(3):261–271. doi: 10.1007/s11420-016-9505-9

Fig. 8.

Fig. 8

a, b The graph shows the risk ratio for THR when comparing bisphosphonates versus controls. a Excluding hips lost to follow-up or excluded from analysis. b Assuming that all hips lost to follow-up or hips excluded from analysis underwent THR (worst-case scenario).